Equities

MEI Pharma Inc

MEIP:NAQ

MEI Pharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)2.81
  • Today's Change0.03 / 1.08%
  • Shares traded5.79k
  • 1 Year change-54.68%
  • Beta0.7950
Data delayed at least 15 minutes, as of Nov 25 2024 15:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue654941
OPERATING EXPENSES
Cost of revenue total----0
Selling, general and admin. expenses, total233331
Depreciation/amortization------
Unusual expense(income)11----
Other operating expenses, total------
Total operating expense5186116
Operating income15(37)(75)
Other, net(0.04)1.5821
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes18(32)(54)
Provision for income taxes----0
Net income after taxes18(32)(54)
Minority interest------
Net income before extra. Items18(32)(54)
Total extraordinary items------
Net income18(32)(54)
Inc.avail. to common excl. extra. Items18(32)(54)
Inc.avail. to common incl. extra. Items18(32)(54)
EPS RECONCILIATION
Basic/primary weighted average shares6.666.666.22
Basic/primary eps excl. extra items2.67(4.78)(8.75)
Basic/primary eps incl. extra items2.67(4.78)(8.75)
Dilution adjustment------
Diluted weighted average shares6.666.666.22
Diluted eps excl. extra items2.67(4.78)(8.75)
Diluted eps incl. extra items2.67(4.78)(8.75)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock1200
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental------
SUPPLEMENTAL INCOME
Depreciation, supplemental0.380.390.33
Total special items11----
NORMALISED INCOME
Normalized income before taxes29(32)(54)
Effect of special items on income taxes0----
Income tax excluding impact of special items0--0
Normalized income after tax29(32)(54)
Normalized income avail. to common29(32)(54)
Basic normalized EPS4.30(4.78)(8.75)
Diluted normalized EPS4.30(4.78)(8.75)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.